News

The FDA has approved Santarus’s New Drug Application (NDA) for immediate-release Omeprazole/sodium bicarbonate/ magnesium hydroxide tablets in 40mg and 20mg dosage strengths of Omeprazole. Santarus had submitted the

Taro Pharmaceutical (Taro) has been granted an Investigational New Drug (IND) exemption by the FDA, to permit clinical studies on T2000 (1,3-dimethoxymethyl-5,5-diphenyl-barbituric acid). T2000 is one of a

Bristol-Myers Squibb and Pfizer are planning to submit an application for regulatory approval of Apixaban in Europe, for the prevention of venous thromboembolism (VTE) after orthopedic surgery, in

Galenea and Otsuka Pharmaceutical have reported the further extension of their research and development collaboration through 2011. The latest extension increases the collaboration term to seven years and

Dicerna Pharmaceuticals (Dicerna) and Kyowa Hakko Kirin have entered into a research collaboration and license agreement for the research, development and commercialisation of drug delivery systems and DsiRNA

Radient Pharmaceuticals has received approval from the Korean FDA (KFDA) for Onko-Sure in-vitro diagnostic cancer test for routine clinical testing and government reimbursement throughout Korea. The company has

Merck & Co has received FDA approval for Zegerid OTC (omeprazole 20mg/sodium bicarbonate 1100mg capsules), for over-the-counter treatment of frequent heartburn. Zegerid OTC will be marketed over-the-counter by

Milestone Scientific (Milestone) has entered into a joint venture with China National Medicines (d/b/a Sinopharm) and Yichang Humanwell Pharmaceutical (Yichang Humanwell), to develop orthopedic and epidural drug delivery

Caliper Life Sciences (Caliper) has introduced Living Image 4.0 software for IVIS in vivo imaging systems. Living Image software drives the more than 800 Caliper IVIS systems currently